Merck Tbk PT

Merck Tbk PT EPS

The Earnings per Share (EPS) of Merck Tbk PT (MERK.JK) as of Nov 3, 2026 is 544.41 IDR. In the previous year, Earnings per Share (EPS) was 342.55 IDR — a change of 58.93% (higher).

EPS

544.41IDR

YoY

58.93%

Last updated:

Earnings per Share (EPS) of Merck Tbk PT is 2025 544.41 IDR. Earnings per Share (EPS) of Merck Tbk PT was 2024 342.55 IDR. It decreases by 58.93% higher compared to the previous year.

The Merck Tbk PT EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
2,596.71 IDR
Jan 1, 2019
174.68 IDR
Jan 1, 2020
160.50 IDR
Jan 1, 2021
293.89 IDR
Jan 1, 2022
401.42 IDR
Jan 1, 2023
397.86 IDR
Jan 1, 2024
342.55 IDR
Jan 1, 2025
544.41 IDR
The Merck Tbk PT EPS history
YEAREPSYoY
544.41IDR+58.93%
342.55IDR-13.90%
397.86IDR-0.89%
401.42IDR+36.59%
293.89IDR+83.11%
160.50IDR-8.12%
174.68IDR-93.27%
2,596.71IDR+704.08%
322.94IDR-5.96%
343.40IDR+7.62%
319.08IDR-21.21%
404.97IDR+3.43%
391.54IDR+62.70%
240.64IDR-53.36%
515.98IDR+94.59%
265.17IDR-19.02%
327.46IDR+48.75%
220.13IDR+10.21%
199.74IDR+3.41%
193.16IDR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT generates revenue through its Biopharma segment, which focuses on ethical pharmaceutical products for serious diseases. The company also earns from Consumer Health, offering over-the-counter products that support personal wellness and family planning needs. Its 'Others' segment includes additional business activities. The firm serves healthcare providers, pharmacies, and individual consumers seeking personalized treatments and accessible health solutions. Biopharma targets medical professionals and hospitals with specialized treatments for critical conditions. Consumer Health products are sold directly to consumers through retail channels for daily health management. The company's business model relies on delivering tailored healthcare solutions across its three operational segments to meet diverse market demands. Merck Tbk PT's revenue streams are structured around pharmaceutical innovations and consumer health products. Ethical products in Biopharma address unmet medical needs, while over-the-counter offerings in Consumer Health cater to everyday health requirements. The firm's focus on personalized care ensures consistent demand from both professional and individual customers. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

Earnings per Share (EPS) of Merck Tbk PT is 544.41 IDR in 2025.

Earnings per Share (EPS) of Merck Tbk PT changed from 342.55 IDR to 544.41 IDR, representing a 58.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Merck Tbk PT

All Key Metrics — Merck Tbk PT